Piezo1-A Key Pathogenic Factor in Breast Implant-Associated Capsular Contracture

Area of Science:

• Biomedical Engineering
• Cell Biology
• Surgical Complications

Background:

• Capsular contracture (CC) is a common complication after breast implant surgery with unclear mechanisms.
• The role of the mechanosensitive ion channel Piezo1 in breast implant-associated fibrosis was previously unknown.

Purpose of the Study:

• To investigate Piezo1 expression in breast implant-associated capsular contracture.
• To determine the functional role of Piezo1 in the pathogenesis of CC.
• To evaluate Piezo1 as a potential therapeutic target for CC.

Main Methods:

• Utilized a murine silicone-implanted model to analyze Piezo1 expression during capsule formation.
• Examined Piezo1 expression in human capsular tissues (normal and contracted).
• Employed a lipoteichoic acid (LTA)-induced contracture model to test the Piezo1 inhibitor GsMTx4, using histology, immunofluorescence, and Western blot.

Main Results:

• Piezo1 expression significantly increased during early capsule formation in mice, correlating with collagen deposition and capsular thickening.
• Human contracted capsules showed markedly higher Piezo1 levels than normal capsules.
• GsMTx4 treatment substantially reduced collagen deposition, capsular thickness, and Piezo1 levels in the LTA-induced contracture model.

Conclusions:

• Piezo1 is a critical mediator in the pathogenesis of breast implant-associated capsular contracture.
• The dynamic expression of Piezo1 and the efficacy of its inhibition highlight its role in fibrotic processes.
• Piezo1 inhibition presents a promising novel therapeutic strategy for preventing capsular contracture.